Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Mabpharm Limited Governance Information 2025

Oct 31, 2025

50428_rns_2025-10-31_d5881e1e-35d9-405f-ae1e-c8fb881d8be5.pdf

Governance Information

Open in viewer

Opens in your device viewer

  • 1 -

img-0.jpeg

邁博藥業

Mabpharm Limited

迈博药业有限公司

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 2181)

LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS

The members of the board (the "Board") of directors (the "Director(s)") of Mabpharm Limited (the "Company") are set out below:

Executive Directors

Dr. Wang Hao (Chief Executive Officer)
Mr. Li Yunfeng
Mr. Tao Jing
Dr. Hou Sheng
Dr. Qian Weizhu

Non-executive Directors

Mr. Jiao Shuge (Chairman)
Mr. Cen Jialin

Independent Non-executive Directors

Dr. Zhang Yanyun (Lead Independent Non-executive Director)
Mr. Guo Liangzhong
Mr. Leung, Louis Ho Ming
Dr. Tao Qian


The Board has set up three committees with defined terms of reference. The membership information of these committees is set out below:

Audit Committee

Mr. Leung, Louis Ho Ming (Chairman)
Mr. Jiao Shuge
Mr. Guo Liangzhong

Remuneration Committee

Dr. Zhang Yanyun (Chairman)
Dr. Wang Hao
Mr. Guo Liangzhong

Nomination Committee

Mr. Guo Liangzhong (Chairman)
Dr. Qian Weizhu
Dr. Zhang Yanyun

Hong Kong, October 31, 2025

  • 2 -